Iron Metabolism in Cancer and Senescence: A Cellular Perspective
Elvira Crescenzi1, Antonio Leonardi2, Francesco Pacifico1
1Istituto per l'Endocrinologia e l'Oncologia Sperimentale, CNR, Via S. Pansini, 5, 80131 Naples, Italy.
Biology
|July 29, 2023
Summary
Iron metabolism is crucial for cellular homeostasis. Dysregulation of iron is linked to cancer progression and cellular senescence, but its specific role in senescence requires further investigation.
Area of Science:
- Cellular Biology
- Biochemistry
- Oncology
Background:
- Iron is essential for cellular homeostasis and biological processes.
- Altered iron metabolism is a hallmark of cancer, driving aggressive behaviors like proliferation and metastasis.
- Iron dysregulation is also observed in aging and cellular senescence, with iron accumulation in aged tissues and senescent cells.
Purpose of the Study:
- To provide an overview of iron metabolism and its regulatory proteins.
- To summarize the alterations in iron homeostasis in cancer and cellular senescence.
- To highlight the under-characterized role of iron metabolism in senescence.
Main Methods:
- Literature review of iron metabolism and regulatory proteins.
- Synthesis of existing research on iron homeostasis in cancer.
- Analysis of studies investigating iron alterations in cellular senescence.
Main Results:
- Iron metabolism is critical for maintaining cellular balance.
- Cancer cells exhibit significant alterations in iron metabolism, promoting malignant phenotypes.
- Senescent cells, both replicative and stress-induced, show increased iron content.
Conclusions:
- Iron metabolism plays a significant role in both cancer and senescence.
- Further research is needed to fully elucidate the mechanisms of iron regulation and its impact on senescence.
- Understanding iron's role could offer new therapeutic strategies for cancer and age-related diseases.
Related Concept Videos
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
01:46Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
01:37Mitochondria
13.8K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.8K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:22PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K